MedTrace Logo

Pilot Study on the Effect of Intrathecal Opioids on Immune Function in Humans With Cancer Pain

NCT02151513 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 51

Last updated 2023-06-09

No results posted yet for this study

Summary

The purpose of this study is to examine the changes in immune function, as measured by biomarkers in the blood, that happen with intrathecal (spinal) delivery of opioid medications for the treatment of moderate to severe cancer pain.

Hypothesis: Treatment of pain with intrathecal (spinal) therapy is associated with little alteration of immune function as measured by biomarkers in the blood of cancer patients with moderate to severe pain.

Conditions

  • Cancer-associated Pain

Interventions

DEVICE

Intrathecal Pump Placement

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-01
Primary Completion
2018-06-01
Completion
2018-06-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02151513 on ClinicalTrials.gov